DVT Screening and Treatment Devices

DVT Screening and Treatment Devices Market Outlook

The global Deep Vein Thrombosis (DVT) screening and treatment devices market is poised to reach approximately USD 5.1 billion by 2035, with a compound annual growth rate (CAGR) of around 7.5% from 2025 to 2035. This growth can be attributed to a rising prevalence of lifestyle-related health issues, increased awareness regarding DVT, and advancements in medical technology that enhance diagnostic capabilities and treatment options. Furthermore, aging populations across various regions, along with healthcare reforms focusing on improved patient outcomes, are boosting the market demand for effective DVT screening and treatment solutions. The collaboration between healthcare providers and technology firms to develop innovative devices is another critical factor contributing to market expansion. Overall, the DVT screening and treatment devices market is on an upward trajectory, driven by both demand and innovation.

Growth Factor of the Market

Several factors are significantly contributing to the growth of the DVT screening and treatment devices market. The increasing incidence of venous thromboembolism (VTE) is a primary driver, as studies suggest that DVT occurs in approximately 1 in 1,000 individuals, leading to heightened demand for effective screening and treatment devices. Furthermore, the growing elderly population, especially in developed regions, is more susceptible to DVT, thereby amplifying the need for preventive measures and diagnostic technology. Additionally, advancements in medical imaging technologies, such as ultrasound and CT scans, have improved the accuracy and efficiency of DVT diagnostics, creating a favorable environment for market growth. The rise of outpatient surgical procedures and an increase in the number of ambulatory surgical centers are also impacting demand positively, as these facilities require effective DVT management solutions. Finally, public awareness campaigns emphasizing the importance of DVT screening have led to proactive healthcare measures among the general population, further driving the market forward.

Key Highlights of the Market

• The global DVT screening and treatment devices market is expected to reach USD 5.1 billion by 2035.
• North America holds the largest market share due to advanced healthcare infrastructure and high awareness levels regarding DVT.
• The compression stockings segment is predicted to dominate the product type market owing to their widespread usage.
• Technological advancements in ultrasound and blood testing methods are revolutionizing DVT diagnostics.
• Opportunities in emerging markets like Asia Pacific are expected to grow due to increasing healthcare investments.

By Product Type

Compression Stockings:

Compression stockings represent a significant segment within the DVT screening and treatment devices market. These stockings are designed to apply graduated pressure to the legs, promoting better blood flow and reducing the risk of clot formation. The increasing awareness of their benefits, especially among at-risk populations such as post-operative patients and the elderly, has led to a rise in their adoption. Additionally, innovations in fabric technology that enhance comfort and efficacy are further driving this segment's growth. Patients appreciate the ease of use and effectiveness of compression stockings, making them a preferred choice for both preventative and treatment measures. As healthcare providers emphasize preventive care, the demand for compression stockings continues to surge, making it a cornerstone of the DVT treatment market.

Sequential Compression Devices:

Sequential compression devices (SCDs) are integral in the management and prevention of DVT, particularly in hospital settings. These devices utilize inflatable cuffs that sequentially compress the limbs to enhance venous return and prevent stagnation of blood flow. The growing awareness of VTE and its complications among healthcare providers is supporting the increased use of SCDs in both inpatient and outpatient settings. Furthermore, innovations in device design and usability have made them more appealing to healthcare professionals, ensuring improved patient compliance. The efficacy of SCDs in preventing DVT, especially after surgeries or during long periods of immobility, is well-documented, leading to their widespread use across various healthcare environments.

Inferior Vena Cava Filters:

Inferior vena cava (IVC) filters are crucial for preventing pulmonary embolism in patients who cannot take anticoagulants. These devices are inserted into the inferior vena cava to catch blood clots before they can travel to the lungs. The increasing prevalence of DVT and the associated risk of serious complications are driving the demand for IVC filters. Moreover, advancements in filter technology, such as retrievable IVC filters, have expanded their use in clinical practice. Healthcare professionals are more likely to recommend these filters due to their proven safety and efficacy profiles. As guidelines and protocols evolve surrounding DVT management, the market for IVC filters is expected to continue growing, especially in high-risk patient populations.

Compression Pumps:

Compression pumps play a pivotal role in the DVT treatment landscape, particularly for patients who require extensive therapy for venous disorders. These devices apply intermittent pneumatic compression to the legs, significantly improving venous circulation and reducing the risk of clot formation. The growing focus on non-invasive treatment options is enhancing the appeal of compression pumps, as they provide effective management without the need for medication. Furthermore, the introduction of portable and user-friendly models is making these devices more accessible for homecare settings. As healthcare systems shift towards outpatient care models, the use of compression pumps is anticipated to rise, driven by their effectiveness and the increasing number of patients requiring long-term management of venous conditions.

D-Dimer Tests:

D-Dimer tests are critical diagnostic tools utilized in the assessment of DVT, enabling healthcare providers to rule out thrombosis in patients presenting with symptoms. The increasing number of diagnostic centers and hospitals adopting these tests is propelling their market growth. The test's ability to provide rapid and reliable results makes it an essential component of DVT screening protocols. Furthermore, advancements in testing technology and the growing emphasis on early diagnosis are enhancing the utilization of D-Dimer tests in clinical practice. As awareness regarding DVT and its potential complications continues to increase, the demand for reliable diagnostic tests like D-Dimer is expected to rise, thus contributing to the overall expansion of the DVT screening and treatment devices market.

By Application

Hospitals:

Hospitals serve as a primary application segment for DVT screening and treatment devices due to the high volume of surgical procedures performed daily. Surgical patients are at a significant risk for developing DVT, prompting hospitals to implement comprehensive screening and preventative measures. The integration of advanced diagnostic equipment and treatment modalities, including DVT-specific protocols, is becoming increasingly commonplace. Hospitals are investing in training staff to ensure adherence to best practices for DVT prevention, thereby driving the demand for various screening and treatment devices. The emphasis on patient safety and reduced hospital-acquired conditions makes hospitals a crucial market for DVT management devices.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining prominence as an essential application area for DVT screening and treatment devices, driven by the rising number of outpatient procedures. These centers often cater to patients undergoing same-day surgeries, who may be at increased risk for DVT due to prolonged immobility. ASCs are adopting preventive measures, such as the use of compression stockings and sequential compression devices, to mitigate risks associated with DVT. The growing trend towards outpatient care is expected to fuel the demand for efficient DVT management solutions in ASCs, allowing them to maintain high standards of patient care and minimize complications related to venous thromboembolism.

Diagnostic Centers:

Diagnostic centers play a pivotal role in the early detection and management of DVT, utilizing advanced technology to provide precise testing and screening solutions. With the increasing prevalence of DVT, these centers are experiencing rising demand for diagnostic tools, such as D-Dimer tests and imaging technologies. The ability of diagnostic centers to offer rapid results and facilitate timely treatment decisions is a significant advantage, making them an important player in the DVT market. Furthermore, as patients become more proactive about their health and seek out diagnostic services, the importance of these centers is expected to continue growing, leading to a broader adoption of DVT screening and treatment devices.

Homecare Settings:

The homecare settings application segment is increasingly significant in the DVT screening and treatment devices market as healthcare trends shift towards patient-centered care. The convenience of administering treatment from home is appealing to patients, particularly those with chronic conditions that require ongoing management. Devices such as portable compression pumps and wearable compression stockings are being adopted for use in homecare settings, enabling patients to effectively manage their risk of DVT without frequent hospital visits. The growing emphasis on telehealth and remote monitoring is also supporting this trend, as healthcare providers can monitor patient compliance and outcomes more effectively. As a result, the homecare market is poised for substantial growth, driven by the ongoing shift towards decentralized healthcare delivery.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies represent a significant distribution channel for DVT screening and treatment devices, primarily due to the high patient turnover and the immediate need for therapeutic interventions. Hospitals are increasingly stocking a range of DVT management devices to ensure that patients receive timely care during their stay. The collaboration between hospital pharmacists and healthcare providers is essential in ensuring the appropriate use of these devices. Furthermore, the rising incidence of DVT in hospitalized patients necessitates the availability of effective management solutions on-site, reinforcing the hospital pharmacy's critical role in the distribution network of DVT devices.

Retail Pharmacies:

Retail pharmacies are becoming an important distribution channel for DVT screening and treatment devices, catering to a growing number of consumers seeking preventive measures. The availability of over-the-counter products, such as compression stockings, enhances accessibility for individuals at risk of DVT. Retail pharmacies are also providing valuable education regarding the symptoms and risk factors associated with DVT, further supporting consumer awareness and demand. The trend towards self-care and preventive health measures is encouraging more patients to visit retail pharmacies for their DVT management needs, leading to increased sales and market penetration in this segment.

Online Stores:

Online stores are revolutionizing the distribution of DVT screening and treatment devices, offering consumers a convenient platform to purchase necessary products from the comfort of their homes. The rise of e-commerce has led to a significant increase in the availability of various DVT management devices, including compression stockings and pneumatic compression systems. This shift towards online purchasing is being driven by the growing preference for home healthcare solutions and the convenience of direct delivery to patients. Moreover, online retailers often provide comprehensive product information and customer reviews, enabling consumers to make informed decisions about their DVT management options. Consequently, this distribution channel is expected to experience substantial growth as more patients seek out online solutions for their healthcare needs.

By Technology

Ultrasound:

Ultrasound technology is a cornerstone in the diagnostics of DVT, leveraging high-frequency sound waves to visualize blood flow in the veins. This non-invasive technique is widely preferred due to its accuracy and ability to provide real-time results, making it indispensable in clinical settings. The growing awareness of DVT, coupled with advancements in ultrasound technology, has led to increased utilization in both hospitals and outpatient settings. Enhanced imaging capabilities, such as Doppler ultrasound, facilitate the assessment of venous patency and the identification of clots, improving diagnostic confidence. As healthcare providers continue to prioritize accurate and timely diagnostics, the demand for ultrasound technology in DVT screening will likely sustain its growth trajectory.

Blood Tests:

Blood tests, particularly D-Dimer tests, are critical in the diagnostic workup for DVT, providing rapid and reliable results to assist healthcare professionals. D-Dimer tests measure the presence of fibrin degradation products in the blood, serving as a key indicator of clot formation and breakdown. The increasing emphasis on early diagnosis and risk stratification for DVT has led to higher adoption rates of these tests in clinical practice. Their ability to rule out DVT in patients with low risk is also contributing to their growing relevance in emergency departments and outpatient clinics. As the healthcare industry continues to advocate for efficient diagnostic protocols, the utilization of blood tests for DVT screening is expected to rise significantly.

Venography:

Venography is a specialized imaging technique that involves the use of X-rays to visualize the veins after a contrast dye is injected. This method allows for precise assessment of the venous system, making it highly effective for diagnosing DVT. However, due to its invasive nature and the need for specialized equipment, venography is less common than ultrasound or other non-invasive techniques. Nonetheless, in cases where other diagnostic methods are inconclusive, venography remains a standard reference for confirming DVT diagnosis. As the demand for comprehensive vascular imaging grows, advancements in venography techniques and technology may see a resurgence in its use within the DVT screening and treatment landscape.

CT Scan:

Computed Tomography (CT) scans play a crucial role in the diagnosis of DVT, particularly in patients with complex presentations or in cases where other imaging modalities are insufficient. CT venography, in particular, provides detailed images of the venous system, allowing for the detection of clots in larger vessels. The growing prevalence of DVT and the need for accurate diagnostic methods are driving the increasing adoption of CT scans in clinical practice. Moreover, advancements in CT technology, such as faster scanning times and improved image quality, enhance the utility of this method in both emergency and outpatient settings. As healthcare systems continue to seek efficient and effective diagnostic solutions, the role of CT scans in DVT screening is expected to expand.

By Region

North America dominates the global DVT screening and treatment devices market, accounting for approximately 40% of the total market share in 2023. The region's advanced healthcare infrastructure, coupled with high awareness levels about DVT and its management, significantly contributes to its leading position. Furthermore, the increasing number of surgical procedures and an aging population in North America are driving the demand for effective DVT management solutions. The market in this region is expected to grow at a CAGR of 8% from 2025 to 2035, primarily due to ongoing investments in healthcare technologies and initiatives aimed at improving patient outcomes.

Europe is another significant market for DVT screening and treatment devices, holding around 30% of the global market share. Factors such as increasing healthcare awareness, a growing elderly population, and advancements in medical technologies are enhancing the adoption of DVT management solutions across the region. The European market is expected to grow steadily, driven by healthcare reforms focusing on preventive care and the expansion of outpatient surgical centers. Emerging markets in Asia Pacific are also witnessing rapid growth in the DVT devices sector, fueled by improving healthcare infrastructure and rising disposable incomes, which are paving the way for better access to DVT screening and treatment options.

Opportunities

The DVT screening and treatment devices market presents numerous opportunities for growth, particularly in emerging markets such as Asia Pacific and Latin America. These regions are experiencing rapid economic development and improving healthcare infrastructure, leading to increased access to advanced diagnostic and treatment modalities. As awareness regarding DVT continues to rise, there is a burgeoning demand for effective screening and treatment solutions. Companies looking to expand their operations can capitalize on this opportunity by introducing innovative products tailored to the needs of patients in these underserved markets. Furthermore, partnerships with local healthcare providers and stakeholders can facilitate market entry and enhance product distribution, contributing to overall market growth.

Additionally, ongoing advancements in technology and the introduction of digital health solutions present valuable opportunities for companies in the DVT devices sector. The integration of telemedicine and remote monitoring can enhance patient engagement and adherence to treatment protocols, thereby improving health outcomes. Companies that invest in research and development to create smart devices capable of real-time monitoring and data collection stand to gain a competitive advantage. As the healthcare landscape evolves, there is an increasing need for integrated solutions that not only diagnose but also manage DVT effectively, creating a dynamic opportunity for innovation in this market.

Threats

Despite the promising growth of the DVT screening and treatment devices market, several threats could hinder its expansion. The presence of stringent regulatory frameworks governing the approval and use of medical devices can lead to delays in market entry for new products. Companies must navigate complex approval processes, which can be resource-intensive and may create barriers to innovation. Moreover, increasing competition from both established players and new entrants can lead to price wars, negatively impacting profit margins. Additionally, the economic challenges faced by healthcare systems, including budget constraints and funding cuts, may limit the adoption of advanced DVT screening and treatment solutions in certain regions. These external pressures can pose significant challenges for market participants, necessitating strategic planning and adaptability to thrive in this competitive landscape.

Furthermore, there is a risk of market saturation in developed regions, where a significant share of the population is already aware of DVT management solutions. This saturation could lead to diminished growth rates and increased competition for market share. Companies must continuously innovate and differentiate their products to maintain relevance and appeal to healthcare providers and patients. Additionally, the rising trend of DIY healthcare and self-diagnosis poses a challenge, as patients may opt for non-prescription solutions without professional guidance. This shift could undermine the utilization of clinically validated DVT management devices, impacting overall market performance and growth potential.

Competitor Outlook

• Becton, Dickinson and Company
• Medtronic plc
• Boston Scientific Corporation
• Cordis Corporation
• Cook Medical
• Smith & Nephew plc
• Teleflex Incorporated
• 3M Company
• Huntleigh Healthcare
• Arjo Medical
• Getinge AB
• Koninklijke Philips N.V.
• Sysmex Corporation
• Fresenius Kabi AG
• Innovative Health Solutions

The competitive landscape of the DVT screening and treatment devices market is characterized by a mix of well-established companies and emerging players. Market leaders, such as Becton, Dickinson and Company and Medtronic plc, continue to dominate through their extensive product portfolios and significant investments in research and development. These companies are focused on innovation, aiming to develop advanced diagnostic tools and treatment devices that address the evolving needs of healthcare providers and patients. Furthermore, they are leveraging strategic partnerships and collaborations to enhance their market presence and expand their global reach. The competitive rivalry is intensified by the rapid pace of technological advancements and the increasing emphasis on patient-centered care, compelling companies to innovate continuously.

Emerging players are also making inroads into the market by offering niche products and solutions tailored to specific patient needs. Companies like Teleflex Incorporated and Huntleigh Healthcare are focusing on developing user-friendly devices that enhance patient comfort and compliance. This trend towards patient-centricity is becoming increasingly important, as healthcare providers seek to improve treatment adherence and outcomes. Moreover, technological advancements, such as the integration of digital health solutions, are providing new opportunities for both established and emerging companies to differentiate themselves in the market. As competition intensifies, companies must also be cognizant of regulatory requirements and the need for clinical validation of their products, ensuring they meet the highest standards of safety and efficacy.

In conclusion, the DVT screening and treatment devices market presents a dynamic and competitive environment, offering significant growth opportunities driven by increasing awareness, technological advancements, and changing healthcare landscapes. Major companies like Boston Scientific Corporation and Cook Medical are leading the charge with innovative solutions, while the rise of emerging players adds a layer of complexity to the competitive landscape. The focus on patient-centered care and technological integration is expected to shape the future of this market, making it essential for companies to remain agile and responsive to the evolving needs of healthcare providers and patients alike. As the demand for effective DVT management solutions continues to grow, the competition will become fiercer, driving further innovation and advancements in the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Getinge AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Arjo Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Fresenius Kabi AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cordis Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Smith & Nephew plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Sysmex Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Huntleigh Healthcare
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Koninklijke Philips N.V.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Innovative Health Solutions
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Becton, Dickinson and Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 DVT Screening and Treatment Devices Market, By Technology
    • 6.1.1 Ultrasound
    • 6.1.2 Blood Tests
    • 6.1.3 Venography
    • 6.1.4 CT Scan
  • 6.2 DVT Screening and Treatment Devices Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Ambulatory Surgical Centers
    • 6.2.3 Diagnostic Centers
    • 6.2.4 Homecare Settings
  • 6.3 DVT Screening and Treatment Devices Market, By Product Type
    • 6.3.1 Compression Stockings
    • 6.3.2 Sequential Compression Devices
    • 6.3.3 Inferior Vena Cava Filters
    • 6.3.4 Compression Pumps
    • 6.3.5 D-Dimer Tests
  • 6.4 DVT Screening and Treatment Devices Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 DVT Screening and Treatment Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global DVT Screening and Treatment Devices market is categorized based on

By Product Type

• Compression Stockings
• Sequential Compression Devices
• Inferior Vena Cava Filters
• Compression Pumps
• D-Dimer Tests

By Application

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Homecare Settings

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Stores

By Technology

• Ultrasound
• Blood Tests
• Venography
• CT Scan

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Becton, Dickinson and Company
• Medtronic plc
• Boston Scientific Corporation
• Cordis Corporation
• Cook Medical
• Smith & Nephew plc
• Teleflex Incorporated
• 3M Company
• Huntleigh Healthcare
• Arjo Medical
• Getinge AB
• Koninklijke Philips N.V.
• Sysmex Corporation
• Fresenius Kabi AG
• Innovative Health Solutions